DelveInsight’s Infusion Pumps Market report delivers a comprehensive analysis of the market by Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and Patient-Controlled Analgesia Pumps), by Application (Diabetes, Oncology, Pain Management, Gastroenterology, and Others), by End-User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Unlock detailed insights into the Infusion Pumps Market by downloading the comprehensive report from DelveInsight @ https://www.delveinsight.com/sample-request/infusion-pumps-market?utm_source=pngw&utm_medium=promotion&utm_campaign=kkpr
Key Takeaways from the Infusion Pumps Market Report
- The global infusion pumps market was valued at USD 13.80 billion in 2024, growing at a CAGR of 9.54% during the forecast period from 2025 to 2032, to reach USD 23.85 billion by 2032.
- In April 2025, ICU Medical Inc. announced FDA 510(k) clearance for the Plum Solo precision IV pump, a single-channel addition to the Plum Duo system.
- In April 2024, Baxter announced the U.S. FDA clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software.
- According to the International Diabetes Federation, in 2021, approximately 537 million adults aged 20–79 were living with diabetes — a number projected to rise to 643 million by 2030 and 783 million by 2045.
- According to GLOBOCAN, in 2022, an estimated 20 million new cancer cases were recorded globally, with projections indicating a rise to 32.6 million by 2045.
- According to the WHO (2022), healthcare-associated infections (HAIs) affect hundreds of millions annually — 7 out of every 100 patients in high-income countries and 15 in low- and middle-income countries acquire at least one HAI in acute care hospitals.
- North America is expected to account for the highest proportion of the infusion pumps market, driven by the increasing prevalence of cancer, diabetes, a high volume of surgical procedures, and growing emphasis on infection control.
- The leading Infusion Pumps Companies include B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Medtronic plc., Fresenius Kabi, CareFusion Corporation, Smiths Medical, Koninklijke Philips NV, Micrel Medical Devices SA, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Johnson & Johnson, CME Medical UK Ltd., BD, and others.
Gain a competitive edge in the Infusion Pumps Market by exploring our in-depth analysis @ https://www.delveinsight.com/sample-request/infusion-pumps-market?utm_source=pngw&utm_medium=promotion&utm_campaign=kkpr
Infusion Pumps Market Segmentation
- By Type: Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and Patient-Controlled Analgesia Pumps
- By Application: Diabetes, Oncology, Pain Management, Gastroenterology, and Others
- By End-User: Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others
- By Geography: North America, Europe, Asia-Pacific, and Rest of the World
Download the report to understand which factors are driving Infusion Pumps Market Trends @ https://www.delveinsight.com/sample-request/infusion-pumps-market?utm_source=pngw&utm_medium=promotion&utm_campaign=kkpr
Infusion Pumps Market Dynamics
The infusion pumps market is driven by the rising incidence of chronic illnesses such as cancer, diabetes, and other conditions. This rise in chronic conditions often requires prolonged and precise medication management, which infusion pumps are uniquely designed to provide. These devices ensure accurate and consistent delivery of medications, vital for managing complex treatment regimens. Advanced safety features and sterile pathways within modern infusion pumps also play a crucial role in minimizing the risk of hospital-acquired infections (HAIs), which affect hundreds of millions of patients annually.
Infusion pumps are equally essential in surgical settings for administering anesthesia, pain management, and post-operative care. Furthermore, infusion pumps that support remote monitoring enable healthcare providers to manage patients’ conditions effectively from a distance — a capability that is especially crucial for chronic disease management. The continuous influx of new products and technologies ensures the market remains dynamic and innovative throughout the forecast period.
However, stringent regulatory hurdles for gaining product approval and the risk of infections due to improper handling, poor aseptic techniques, or environmental exposure — which can cause bloodstream infections, localized infection at the infusion site, sepsis, and other complications — may hinder the market during the forecast period.
Infusion Pumps Market Segment Analysis
Insulin Pumps — Leading Type Segment
In the type segment of the infusion pump market, insulin pumps are projected to hold a considerable market share. Insulin pumps provide precise control over insulin delivery, allowing for customizable basal rates and bolus doses tailored to individual patient needs. This precision helps achieve tighter glycemic control and reduces the risk of hypoglycemia and hyperglycemia — critical concerns in diabetes management. Modern insulin pumps are equipped with advanced features such as continuous glucose monitoring (CGM) integration, predictive algorithms for insulin dosing adjustments, and connectivity with mobile apps or cloud-based platforms. The increasing global cases of Type-1 diabetes further propel this segment, with the International Diabetes Federation reporting that around 8.75 million people with diabetes were living with the condition in 2022, including 1.52 million under age 20.
North America — Dominant Regional Market
North America is expected to account for the highest proportion of the infusion pumps market. This can be ascribed to the increasing prevalence of cancer, diabetes, and other diseases across the region, the presence of a large number of key market players, and a high volume of surgical procedures. According to GLOBOCAN, North America saw an estimated 2.67 million new cases of cancer in 2022, with forecasts indicating a rise to 3.83 million by 2045. The growing emphasis on infection control and the increase in hospital admissions — with U.S. hospitals recording a total of 33,679,935 admissions in 2022 per the American Hospital Association — further fuel the adoption of advanced infusion pumps.
Discover key developments and opportunities in the Infusion Pumps Market @ https://www.delveinsight.com/sample-request/infusion-pumps-market?utm_source=pngw&utm_medium=promotion&utm_campaign=kkpr
Infusion Pumps Companies
B. Braun Melsungen AG | Baxter International Inc. | Boston Scientific Corporation | Medtronic plc. | Fresenius Kabi | CareFusion Corporation | Smiths Medical | Koninklijke Philips NV | Micrel Medical Devices SA | Terumo Corporation | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | F. Hoffmann-La Roche Ltd. | Johnson & Johnson | CME Medical UK Ltd. | BD | and others
Infusion Pumps Market Outlook
The global infusion pumps market is poised for significant and sustained growth throughout the forecast period from 2025 to 2032. The increasing prevalence of chronic diseases such as cancer and diabetes, combined with the expanding need for precise medication management across hospital and home care settings, is expected to drive strong demand. Technological advancements — including smart pump integration, CGM connectivity, and safety software — are reshaping the competitive landscape and enhancing patient outcomes.
In the type segment, insulin pumps are expected to generate considerable revenue, driven by the global rise in Type-1 and Type-2 diabetes cases and the rapid adoption of advanced wearable devices. In the regional landscape, North America is expected to maintain dominance due to its robust healthcare infrastructure, high surgical volumes, and an active regulatory and product approval environment. Meanwhile, Asia-Pacific is anticipated to present emerging growth opportunities, supported by rising disease prevalence and improving healthcare access.
The continuous influx of regulatory approvals, product innovations, and strategic partnerships among leading companies such as Baxter, ICU Medical, BD, and Medtronic will further fuel market expansion. Overall, the infusion pumps market is expected to grow from USD 13.80 billion in 2024 to USD 23.85 billion by 2032, reflecting a robust CAGR of 9.54%.
Download DelveInsight’s Infusion Pumps Market report today and stay ahead in this rapidly evolving field @\https://www.delveinsight.com/sample-request/infusion-pumps-market?utm_source=pngw&utm_medium=promotion&utm_campaign=kkpr
Scope of the Infusion Pumps Market Report
- Coverage:Global
- Study Period: 2022–2032
- Forecast Period: 2025–2032
- Infusion Pumps CAGR: 9.54%
- Market Size by 2032: USD 23.85 billion
- Key Companies in the Infusion Pumps Market: Baxter International, B. Braun Melsungen AG, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, and other market participants.
- Segments Covered: By Type, By Application, By End-User, and By Geography.
- Geographies Covered: North America, Europe, Asia-Pacific, and Rest of the World.
Table of Contents
- Infusion Pumps Market Report Introduction
- Infusion Pumps Market Executive Summary
- Competitive Landscape
- Regulatory Analysis
- Infusion Pumps Market Key Factors Analysis
- Infusion Pumps Market Porter’s Five Forces Analysis
- Infusion Pumps Market Assessment
- Infusion Pumps Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
